Goldman, Jennifer G. http://orcid.org/0000-0001-5014-7535
Vernaleo, Beth A.
Camicioli, Richard
Dahodwala, Nabila
Dobkin, Roseanne D.
Ellis, Terry
Galvin, James E.
Marras, Connie
Edwards, Jerri
Fields, Julie
Golden, Robyn
Karlawish, Jason
Levin, Bonnie
Shulman, Lisa
Smith, Glenn
Tangney, Christine
Thomas, Cathi A.
Tröster, Alexander I. http://orcid.org/0000-0002-8898-3878
Uc, Ergun Y.
Coyan, Noreen
Ellman, Crystal
Ellman, Mike
Hoffman, Charlie
Hoffman, Susan
Simmonds, Don
Funding for this research was provided by:
Parkinson's Disease Foundation (Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award, Community Choice Research Award)
Article History
Received: 26 August 2017
Revised: 29 April 2018
Accepted: 10 May 2018
First Online: 26 June 2018
<!--Emphasis Type='Bold' removed-->Competing interests
: J.G.G. has received consulting/advisory board honoraria from Acadia, Aptinyx, Biogen; grants/research support from Acadia, Biotie (site PI), Consolidated Anti-Aging, National Institutes of Health, National Parkinson Foundation, Michael J. Fox Foundation, Rush University; honoraria from American Academy of Neurology, International Parkinson and Movement Disorder Society, MedEdicus; and salary from Rush University Medical Center. B.A.V. has received salary from the Parkinson’s Foundation. R.C. has received research funding from the Canadian Institutes for Health Research (CIHR), Alberta Innovates Solutions, the Alzheimer Society of Canada, University of Alberta Hospital Foundation, and National Institutes of Health and is a site investigator for a pharmaceutical trial sponsored by Axovant (back up site); served on the Scientific advisory board for Michael J. Fox Foundation, the Parkinson’s Disease Foundation, Parkinson Canada, Editorial board for Frontiers in Aging Neurosciences, Dementia and Geriatric Cognitive Disorders, Parkinsonism and Related Disorders, and as safety monitor/scientific advisor for a Harvard University/Tel Aviv University trial of DCTMS and a Western University investigator initiated pharmaceutical trial. N.D. has received grant/research support from the National Institutes of Health, Parkinson’s Foundation, Michael J. Fox Foundation, Parkinson Council, Biotie, Abbvie and salary from the University of Pennsylvania. R.D. has received grant/research support from the Michael J. Fox Foundation, the Parkinson’s Unity Walk, the Veteran Affairs Administration, and the Parkinson’s Foundation; consulting fees from the Michael J. Fox Foundation and the University of Delaware; and salary from Rutgers University. T.E. has received grant/research support from the National Institutes of Health, American Parkinson Disease Association and salary support from Boston University. J.E.G. has received grant/research support from the National Institutes of Health, Florida Department of Health, the Harry T. Mangurian Foundation, and the Association for Frontotemporal Degeneration, serves as a scientific advisor for Axovant, Biogen, Eisai, and Eli Lilly; receives licensing fees from Pfizer, Lilly, Axovant, and Quintiles; conducts on-going clinical trials funded by Biogen, Axovant, and Janssen, and serves on the editorial boards of Neurodegenerative Disease Management, Alzheimer’s Disease and Associated Disorders, and Acta Neuropathologica. C.M. has received grant/research support from The Michael J. Fox Foundation, Canadian Institutes of Health Research, Movement Disorders Society; National Institutes of Health; served as a consultant to Accorda Therapeutics; received honoraria from EMD Serono, steering committee for National Parkinson Foundation; and salary from the University Health Network. J. Edwards serves on Data Safety Monitoring Boards on National Institutes of Health grants awarded to Posit Science Inc. She previously served as a limited consultant to Posit Science Inc. in 2007, and has worked as a consultant to Wilson Sonsini Goodrich & Rosati. J.F. has received grant support from the Patient Centered Outcomes Research Institute, National Institutes of Health, and salary from Mayo Clinic, Rochester, MN. J.K. serves as a site PI for clinical trials sponsored by Novartis and Lilly and as a consultant to John Hancock. L.S. has received grant/research support from the National Institutes of Health, the Michael J. Fox Foundation, and Biotie/Acorda. G.S. has received grant support from the Patient Centered Outcomes Research Institute and National Institutes of Health and the Florida Department of Health; consulting fees from Novartis, the NFL Concussion Settlement Program and book royalties; and salary from the University of Florida, Gainesville. C.T. has received grant/research support from National Institutes of Health; consulting/advisory board honoraria from UpToDate Inc., Viocare Food Intake Advisory Board; and salary from Rush University Medical Center. C.A.T. has received grant/research support from the National Institutes of Health and salary support from Boston University. E.U. has received grant/research support from Michael J. Fox Foundation, National Institutes of Health, Department of Veterans Affairs; honoraria from the American Academy of Neurology; and salary from University of Iowa and Department of Veterans Affairs. The remaing authors declare no competing interests.